Ketamine Therapy for
OCD
What is OCD and how is it treated?
Obsessive-compulsive disorder (OCD) is a chronic mental health condition characterized by recurring, unwanted thoughts and repetitive behaviors. While many patients respond to treatment, others continue to experience persistent symptoms that interfere with daily life.
-
Clinical name
Obsessive-compulsive disorder (OCD) -
Prevalence
More than 2 million Americans -
Typical onset
Late childhood to adolescence -
Standard treatment
Psychotherapy & antidepressants -
Diagnostic criteria
Recurring unwanted thoughts, urges, or fears (obsessions) combined with repetitive behaviors or mental rituals (compulsions) that interfere with daily functioning -
Treatment gap
Average delay of 7–11 years between symptom onset and appropriate care
- Intrusive thoughts
- Compulsive behaviors
- Excessive checking
- Repetitive behaviors
- Persistent doubt
- Anxiety spikes
- Ritualistic routines
- Emotional distress
How ketamine treats OCD
“For many patients, relief begins within hours of their first session — not weeks.”
Unlike traditional antidepressants that can take weeks or months to work, ketamine targets the brain’s glutamate system to help form new neural connections. This process can disrupt entrenched thought patterns and repetitive behaviors, allowing the brain to shift away from obsessive-compulsive cycles.
For many patients, this offers a new option when traditional therapies have not provided sufficient relief.
- Glutamate
- NMDA receptor
- New pathways
- Onset of relief
- Primary mechanism
- Neuroplasticity effect
- Serotonin
- Dopamine
- Onset of relief
- Primary mechanism
- Neuroplasticity effect
The ketamine treatment process
01
Schedule free consultation
02
Begin treatment
03
During treatment
04
Regular sessions
Our physicians design a customized treatment plan for each patient. The induction period lasts 3–4 weeks and includes 6–8 sessions. Maintenance sessions are scheduled based on each patient’s needs.
Rapid relief for OCD
Feel better in hours to days — not weeks. Here’s what the research shows.
Over 70%
Patient response rate
5 years
Proven Spravato efficacy
52%
Remission rate within 4 weeks
2–4 hours
Typical onset of relief
What our patients are saying
- Sarah S.
I had tried everything — therapy, medication, hospitalization. Nothing worked. I felt hopeless. But then I found Keta Medical. After just a few treatments, I started to feel like myself again
- Jim Ellwood, MD
I urge you to consider ketamine therapy and do it with a team that puts compassion and safety first. As a patient and an anesthesiologist, I am happy to be an advocate for Keta Medical.
Treatment options
We offer two evidence-based ketamine treatments: Spravato® nasal spray, for patients who also have treatment-resistant depression, and IV ketamine infusions, both administered under medical supervision.
Spravato®
Esketamine nasal spray
- FDA-approved for treatment-resistant depression
- Based on a ketamine derivative
- In-clinic treatment under physician supervision
- Insurance-covered
- Most patients pay $0–$50 per visit after insurance coverage and available assistance programs.
IV ketamine
Intravenous ketamine infusion
- Treats depression, anxiety, PTSD, OCD, postpartum depression, AUD, and other mental health disorders.
- Available to patients not eligible for Spravato
- Delivered under physician supervision
- Self-pay treatment
- $500 per session
If you’re not sure, we’ll help you understand which option is right for you.
Research on ketamine therapy & OCD
Below are several studies about the effectiveness of ketamine in treating OCD. Ketamine therapy is a subject of ongoing research and is frequently covered in both mainstream media and scientific journals.
Ketamine in the Treatment of obsessive-compulsive disorder
Ketamine in the Treatment of obsessive-compulsive disorder: A Systematic Review
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
In a placebo-controlled trial, 50% of OCD patients treated with IV ketamine achieved a clinically significant response after one week, compared with 0% receiving placebo
Ketamine for treatment-resistant obsessive-compulsive disorder
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study
FAQs
A good candidate for ketamine treatment for OCD is: someone who has persistent, intrusive thoughts or compulsive behaviors that have not improved or plateaued with standard oral medications. Ketamine may be appropriate for individuals who:
- Have treatment-resistant OCD, meaning they’ve tried multiple medications (such as SSRIs) or Exposure and Response Prevention (ERP) therapy without enough relief
- Experience symptoms like depression or anxiety that significantly interfere with daily life or functioning
- Cannot tolerate the side effects of traditional OCD medications
- Are motivated to continue therapy or ERP while receiving ketamine, as ketamine can enhance treatment response
Ketamine infusions are off-label and therefore not covered by insurance. For patients who also have treatment resistant depression, Spravato® (esketamine) may be an option.
Spravato is FDA-approved and many insurance providers will cover it for depression related to OCD. Keta Medical Center will work with your insurer to complete the required prior authorization and provide documentation of your treatment history. Superbills for patients to submit to insurance providers are available.
Not sure yet?
Explore the resources on our site to find out how ketamine treatment can help you heal.